PubRank

Jan Lubiński

Author PubWeight™ 106.64‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Associations of breast cancer risk factors with tumor subtypes: a pooled analysis from the Breast Cancer Association Consortium studies. J Natl Cancer Inst 2010 4.54
2 A genome-wide association study identifies a new ovarian cancer susceptibility locus on 9p22.2. Nat Genet 2009 4.38
3 Genome-wide association study identifies three loci associated with melanoma risk. Nat Genet 2009 3.89
4 GWAS meta-analysis and replication identifies three new susceptibility loci for ovarian cancer. Nat Genet 2013 3.42
5 Genome-wide association study identifies three new melanoma susceptibility loci. Nat Genet 2011 2.29
6 The NOD2 3020insC mutation and the risk of colorectal cancer. Cancer Res 2004 2.01
7 A high proportion of founder BRCA1 mutations in Polish breast cancer families. Int J Cancer 2004 1.96
8 Risk of breast cancer in women with a CHEK2 mutation with and without a family history of breast cancer. J Clin Oncol 2011 1.94
9 Epigenetic analysis leads to identification of HNF1B as a subtype-specific susceptibility gene for ovarian cancer. Nat Commun 2013 1.73
10 A genome-wide association study of upper aerodigestive tract cancers conducted within the INHANCE consortium. PLoS Genet 2011 1.68
11 A novel founder CHEK2 mutation is associated with increased prostate cancer risk. Cancer Res 2004 1.60
12 Early radiation exposures and BRCA1-associated breast cancer in young women from Poland. Breast Cancer Res Treat 2008 1.59
13 Genetic variation at 9p22.2 and ovarian cancer risk for BRCA1 and BRCA2 mutation carriers. J Natl Cancer Inst 2010 1.41
14 Identification and molecular characterization of a new ovarian cancer susceptibility locus at 17q21.31. Nat Commun 2013 1.36
15 A deletion in CHEK2 of 5,395 bp predisposes to breast cancer in Poland. Breast Cancer Res Treat 2006 1.34
16 Mutation analysis of MLH1 and MSH2 genes performed by denaturing high-performance liquid chromatography. J Biochem Biophys Methods 2002 1.30
17 Hereditary ovarian cancer in Poland. Int J Cancer 2003 1.30
18 A variant in FTO shows association with melanoma risk not due to BMI. Nat Genet 2013 1.17
19 Common alleles in candidate susceptibility genes associated with risk and development of epithelial ovarian cancer. Int J Cancer 2011 1.17
20 Germline 657del5 mutation in the NBS1 gene in breast cancer patients. Int J Cancer 2003 1.13
21 Interplay between BRCA1 and RHAMM regulates epithelial apicobasal polarization and may influence risk of breast cancer. PLoS Biol 2011 1.12
22 Mitochondrial NADH-dehydrogenase subunit 3 (ND3) polymorphism (A10398G) and sporadic breast cancer in Poland. Breast Cancer Res Treat 2009 1.05
23 Germline CHEK2 mutations and colorectal cancer risk: different effects of a missense and truncating mutations? Eur J Hum Genet 2006 1.02
24 BRCA1 mutations and prostate cancer in Poland. Eur J Cancer Prev 2008 1.01
25 Breast cancer risk reduction associated with the RAD51 polymorphism among carriers of the BRCA1 5382insC mutation in Poland. Cancer Epidemiol Biomarkers Prev 2003 0.99
26 A low selenium level is associated with lung and laryngeal cancers. PLoS One 2013 0.99
27 The 3020insC allele of NOD2 predisposes to early-onset breast cancer. Breast Cancer Res Treat 2005 0.99
28 Methylenetetrahydrofolate reductase polymorphisms modify BRCA1-associated breast and ovarian cancer risks. Breast Cancer Res Treat 2006 0.98
29 The G84E mutation in the HOXB13 gene is associated with an increased risk of prostate cancer in Poland. Prostate 2013 0.97
30 Polymorphism in the P-glycoprotein drug transporter MDR1 gene in colon cancer patients. Eur J Clin Pharmacol 2005 0.96
31 BRCA1-associated breast and ovarian cancer risks in Poland: no association with commonly studied polymorphisms. Breast Cancer Res Treat 2009 0.95
32 Can selenium levels act as a marker of colorectal cancer risk? BMC Cancer 2013 0.93
33 Inflammatory response gene polymorphisms and their relationship with colorectal cancer risk. BMC Cancer 2008 0.92
34 Comparison of genomic abnormalities between BRCAX and sporadic breast cancers studied by comparative genomic hybridization. Int J Cancer 2005 0.92
35 The risk of gastric cancer in carriers of CHEK2 mutations. Fam Cancer 2013 0.91
36 Germline mutation and large deletion analysis of the CDKN2A and ARF genes in families with multiple melanoma or an aggregation of malignant melanoma and breast cancer. Int J Cancer 2004 0.91
37 Association of common WRAP 53 variant with ovarian cancer risk in the Polish population. Mol Biol Rep 2012 0.90
38 Do BRCA1 modifiers also affect the risk of breast cancer in non-carriers? Eur J Cancer 2008 0.90
39 The VEGF_936_C>T 3'UTR polymorphism reduces BRCA1-associated breast cancer risk in Polish women. Cancer Lett 2008 0.89
40 Prevalence of the NOD2 3020insC mutation in aggregations of breast and lung cancer. Breast Cancer Res Treat 2006 0.89
41 BRCA1 mutations and colorectal cancer in Poland. Fam Cancer 2010 0.89
42 Sulforaphane-mediated induction of a phase 2 detoxifying enzyme NAD(P)H:quinone reductase and apoptosis in human lymphoblastoid cells. Acta Biochim Pol 2004 0.89
43 A common nonsense mutation of the BLM gene and prostate cancer risk and survival. Gene 2013 0.89
44 A six-nucleotide deletion in the CASP8 promoter is not associated with a susceptibility to breast and prostate cancers in the Polish population. Breast Cancer Res Treat 2007 0.89
45 High incidence of 4153delA BRCA1 gene mutations in Lithuanian breast- and breast-ovarian cancer families. Breast Cancer Res Treat 2005 0.88
46 A sex-specific association between a 15q25 variant and upper aerodigestive tract cancers. Cancer Epidemiol Biomarkers Prev 2011 0.88
47 Smoking related cancers and loci at chromosomes 15q25, 5p15, 6p22.1 and 6p21.33 in the Polish population. PLoS One 2011 0.88
48 Germline mutations in the CHEK2 kinase gene are associated with an increased risk of bladder cancer. Int J Cancer 2008 0.88
49 The rs1447295 and DG8S737 markers on chromosome 8q24 and cancer risk in the Polish population. Eur J Cancer Prev 2010 0.87
50 DNA variation in MSR1, RNASEL and E-cadherin genes and prostate cancer in Poland. Urol Int 2007 0.87
51 CHEK2 mutations and HNPCC-related colorectal cancer. Int J Cancer 2010 0.87
52 CDKN2A-positive breast cancers in young women from Poland. Breast Cancer Res Treat 2006 0.87
53 Synergistic interaction of variants in CHEK2 and BRCA2 on breast cancer risk. Breast Cancer Res Treat 2008 0.87
54 Pathology of breast cancer in women with constitutional CHEK2 mutations. Breast Cancer Res Treat 2005 0.86
55 CHEK2 germline mutations correlate with recurrence rate in patients with superficial bladder cancer. Ann Acad Med Stetin 2008 0.85
56 Polymorphisms in nucleotide excision repair genes and susceptibility to colorectal cancer in the Polish population. Mol Biol Rep 2014 0.85
57 The 3' untranslated region C > T polymorphism of prohibitin is a breast cancer risk modifier in Polish women carrying a BRCA1 mutation. Breast Cancer Res Treat 2006 0.85
58 Clinical characteristics of laryngeal cancer in BRCA-1 mutation carriers. Anticancer Res 2009 0.85
59 Fine mapping of genetic susceptibility loci for melanoma reveals a mixture of single variant and multiple variant regions. Int J Cancer 2014 0.84
60 Exploring the link between germline and somatic genetic alterations in breast carcinogenesis. PLoS One 2010 0.83
61 Germline 657del5 mutation in the NBS1 gene in patients with malignant melanoma of the skin. Melanoma Res 2003 0.83
62 Association between early-onset breast and laryngeal cancers. Breast Cancer Res Treat 2005 0.83
63 CDH1 gene mutations do not contribute in hereditary diffuse gastric cancer in Poland. Fam Cancer 2010 0.83
64 PARS PLANA VITRECTOMY IN ADVANCED CASES OF VON HIPPEL-LINDAU EYE DISEASE. Retina 2016 0.82
65 Direct-to-patient BRCA1 testing: the Twoj Styl experience. Breast Cancer Res Treat 2006 0.82
66 Cancer Familial Aggregation (CFA) and G446A polymorphism in ARLTS1 gene. Breast Cancer Res Treat 2006 0.81
67 BARD1 and breast cancer in Poland. Breast Cancer Res Treat 2007 0.81
68 Gene Expression Profiling in Hereditary, BRCA1-linked Breast Cancer: Preliminary Report. Hered Cancer Clin Pract 2006 0.80
69 Antigens HLA-G, sHLA- G and sHLA- class I in reproductive failure. Folia Histochem Cytobiol 2007 0.80
70 Rarity of germline 1100delC mutation in CHK2 in patients with malignant melanoma of the skin. Melanoma Res 2004 0.80
71 The association between the interleukin-1 polymorphisms and gastric cancer risk depends on the family history of gastric carcinoma in the study population. Am J Gastroenterol 2006 0.80
72 Clinical characteristics of tumors derived from colorectal cancer patients who harbor the tumor necrosis factor alpha-1031T/T and NOD2 3020insC polymorphism. Cancer Epidemiol 2009 0.80
73 Genetic heterogeneity of 8q24 region in susceptibility to cancer. J Natl Cancer Inst 2009 0.80
74 The presence of prostate cancer at biopsy is predicted by a number of genetic variants. Int J Cancer 2013 0.79
75 Case report of a woman with monoclonal gammapathy and papillary thyroid carcinoma, diagnosed because of detection of CHEK2 (I157T) mutation in genetic examinations. Endokrynol Pol 2010 0.78
76 Identification of patients at high risk of psychological distress after BRCA1 genetic testing. Genet Test Mol Biomarkers 2009 0.78
77 Polymorphic variants in VAX1 gene (rs7078160) and BMP4 gene (rs762642) and the risk of non-syndromic orofacial clefts in the Polish population. Dev Period Med 2014 0.78
78 Ovarian cancer of endometrioid type as part of the MSH6gene mutation phenotype. J Hum Genet 2002 0.78
79 Low-risk Genes and Multi-organ Cancer Risk in the Polish Population. Hered Cancer Clin Pract 2006 0.78
80 The 3020insC NOD2 gene mutation in patients with ovarian cancer. Ginekol Pol 2008 0.77
81 The variant allele of the rs188140481 polymorphism confers a moderate increase in the risk of prostate cancer in Polish men. Eur J Cancer Prev 2015 0.77
82 Is there any relationship between BRCA1 gene mutation and pancreatic cancer development? Pol Arch Med Wewn 2008 0.77
83 Population screening for cancer family syndromes in the west pomeranian region of poland. Hered Cancer Clin Pract 2006 0.77
84 Consortium analysis of gene and gene-folate interactions in purine and pyrimidine metabolism pathways with ovarian carcinoma risk. Mol Nutr Food Res 2014 0.77
85 Optimizing recruitment to a prostate cancer surveillance program among male BRCA1 mutation carriers: invitation by mail or by telephone. Hered Cancer Clin Pract 2013 0.77
86 Supernormal electro-oculograms in patients with neurofibromatosis type 1. Hered Cancer Clin Pract 2004 0.76
87 Combined iPLEX and TaqMan assays to screen for 45 common mutations in Lynch syndrome and FAP patients. J Mol Diagn 2009 0.76
88 A Lowering of Breast and Ovarian Cancer Risk in Women with a BRCA1 Mutation by Selenium Supplementation of Diet. Hered Cancer Clin Pract 2006 0.76
89 Ovarian cancer risk in Polish BRCA1 mutation carriers is not associated with the prohibitin 3' untranslated region polymorphism. BMC Cancer 2008 0.76
90 Double heterozygotes among breast cancer patients analyzed for BRCA1, CHEK2, ATM, NBN/NBS1, and BLM germ-line mutations. Breast Cancer Res Treat 2014 0.75
91 Corrigendum: Germline RECQL mutations are associated with breast cancer susceptibility. Nat Genet 2016 0.75
92 Dupuytren's disease and the risk of malignant neoplasms. Hered Cancer Clin Pract 2014 0.75
93 Coverage of the genetic background of breast cancer in the polish population. Hered Cancer Clin Pract 2006 0.75
94 A case of carotid body paraganglioma and haemangioblastoma of the spinal cord in a patient with the N131K missense mutation in the VHL gene. Neurol Sci 2011 0.75
95 Nuclear Pedigree Criteria for the Identification of Individuals Suspected to be at Risk of an Inherited Predisposition to Renal Cancer. Hered Cancer Clin Pract 2005 0.75
96 Corrigendum: Rare variants of large effect in BRCA2 and CHEK2 affect risk of lung cancer. Nat Genet 2017 0.75
97 Mutations in the von hippel-lindau tumour suppressor gene in central nervous system hemangioblastomas. Hered Cancer Clin Pract 2004 0.75
98 Nuclear pedigree criteria for the identification of individuals suspected to be at risk of an inherited predisposition to gastric cancer. Hered Cancer Clin Pract 2004 0.75
99 BRCA1 founder mutations compared to ovarian cancer in Belarus. Fam Cancer 2014 0.75
100 Familial association of laryngeal, lung, stomach and early-onset breast cancer. Breast Cancer Res Treat 2007 0.75
101 Retinal dysfunction in eyes of patients with BRCA1 gene mutation. Klin Oczna 2005 0.75
102 Possible association of the BRCA2 gene C5972T variant with gastric cancer: a study on Polish population. Pol Arch Med Wewn 2015 0.75
103 Selenium as marker for cancer risk and prevention. Pol Przegl Chir 2012 0.75
104 Clinical and epidemiological features of familial laryngeal cancer in Poland. Cancer Detect Prev 2007 0.75
105 Ovarian cystadenoma as a characteristic feature of families with hereditary ovarian cancers unassociated with BRCA1 and BRCA2 mutations. J Appl Genet 2004 0.75
106 Clinical characteristics of hereditary ovarian cancer (HOC) in Poland. Ginekol Pol 2002 0.75
107 Electroretinographic changes in eyes of patients with BRCA1 gene mutation. Ophthalmic Res 2003 0.75
108 Retinal function in the von Hippel-Lindau disease. Doc Ophthalmol 2003 0.75
109 Electroretinographic changes in the inner retinal layers of the retained eyes of patients with sporadic unilateral retinoblastoma. Ophthalmic Genet 2002 0.75
110 Usefulness of polymorphic markers in exclusion of BRCA1/BRCA2 mutations in families with aggregation of breast/ovarian cancers. J Appl Genet 2003 0.75
111 Genotyping by induced Förster Resonance Energy Transfer(iFRET) mechanism and simultaneous mutation scanning. Hum Mutat 2013 0.75
112 Population Screening of CHEK2 Mutations in Poland. Hered Cancer Clin Pract 2006 0.75
113 [HLA-G alleles and risk of early pregnancy loss]. Ann Acad Med Stetin 2008 0.75
114 Electro-oculographic and electroretinographic studies in HNPCC gene mutation carriers. Ophthalmic Res 2003 0.75
115 Modest association of malignant melanoma with the rs910873 and rs1885120 markers on chromosome 20: a population-based study. Melanoma Res 2010 0.75
116 Pleomorphic adenoma of salivary glands does not appear to be a BRCA-1-dependent tumour in a Polish cohort. Anticancer Res 2008 0.75